Filed: 8/13/2026ACC: 0001053906-26-000008
📋 What this filing means
ARTAL GROUP S.A. filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $931.12M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$931.12M
Total AUM (reported)
181.66M
Total Shares
Allocation by class
COM$510.75M54.9%
COM NEW$420.37M45.1%
Portfolio Concentration
Top 3$931.12M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 181.66M
Sole
Full voting authority
181.66M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other2
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
Cava Group Inc
DFNDShares6.51M
TypeSH
Market value$510.75M
54.85%
Sole
6.51M
Shared
0.00
None
0.00
Lexicon Pharmaceuticals Inc
DFNDShares175.16M
TypeSH
Market value$420.37M
45.15%
Sole
175.16M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Cava Group IncDFND | COM | 6.51M | SH | $510.75M 54.85% | 6.51M | 0.00 | 0.00 |
Lexicon Pharmaceuticals IncDFND | COM NEW | 175.16M | SH | $420.37M 45.15% | 175.16M | 0.00 | 0.00 |